- Home
- Clinical Trials
Weight Management Studies Melbourne
Weight Management Study
Sunshine Melbourne
Do you have obesity or are you living with overweight and weight-related health conditions?
You may be eligible to join a clinical study evaluating a potential new once-weekly treatment, designed to support long-term weight management.
By taking part, you may gain access to a new investigational treatment, receive regular health checks, and contribute to research that may help shape future care.
Description
What to expect
Study details
Ages
18 years or older
Duration
The study runs for approximately 70 weeks and includes 14 scheduled clinic visits and 6 phone visits. In addition to clinic visits, participants will also be required to attend lifestyle counselling sessions on healthy eating and physical activity. If you have prediabetes at the start of the study, you may be invited to take part in a 2-year extension phase for additional follow-ups.
Compensation
Participants will be compensated for reasonable expenses associated with study visits.
Eligibility Criteria
You may qualify for this study if you:
- Are 18 years or older
- Living with obesity with a BMI ≥30 OR
- Overweight with a BMI ≥27 AND have at least one of the following:
- High Blood Pressure (Hypertension)
- High Cholesterol (Dyslipidemia)
- Sleep apnea
- Cardiovascular disease (e.g., Heart failure, heart disease, history of stroke or heart attack)
- Have not been diagnosed with diabetes (people with prediabetes may be eligible)
Other criteria apply. A member of our team will check if this study is a good fit for you.
Locations
Description
Obesity and overweight are common, long-term health conditions in which the body carries excess weight that can place strain on organs, joints and everyday functioning. Many people experience symptoms such as low energy, breathlessness, disturbed sleep, or discomfort with movement.
These conditions are incredibly prevalent, affecting millions of adults worldwide and impacting physical health, emotional wellbeing, and confidence. They can also influence daily life, from social engagement and work to self-esteem and overall quality of life.
Obesity and overweight are typically managed through healthy eating, increased physical activity, behavioural support, and sometimes medication or surgery when appropriate. While these approaches can help, many people find long-term weight management challenging. This is why ongoing research is exploring new treatment options that may offer safer, more sustainable support.
This study is exploring whether a once-weekly injection may help support long-term weight management alongside healthy eating and physical activity. It works by targeting pathways involved in appetite, eating behaviours, and metabolic regulation.
Researchers aim to understand whether the investigational treatment can:
- Support meaningful reductions in body weight over time
- Help improve appetite control
- Enhance overall wellbeing and quality of life
- For participants with prediabetes: help delay or reduce progression to type two diabetes
What to expect
Participants will be randomly assigned to receive a once-weekly injection of either:
- The investigational treatment
- A placebo (inactive substance)
Alongside the study medication, all participants will receive lifestyle guidance on healthy eating and physical activity.
You will visit the clinic regularly for health assessments, including weight measurements and vital signs, blood tests, questionaries about wellbeing and eating behaviour, and general check-ups. Your safety and well-being will be closely monitored by a professional clinical team.
Why join this clinical research study?
- Gain early access to new potential treatments at no cost
- Contribute to research that could help others living with obesity or overweight
- Learn better ways to manage your health
- Receive health checks and advice from our professional medical team
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.